OTTAWA, CANADA -- (MARKET WIRE) -- February 02, 2007 -- Chemaphor Inc.(TSX VENTURE: CFR), a biotechnology research and development company today announced the appointment of Dr. Christopher Newman to its newly established Scientific Advisory Board and the appointment of Mark Goudie to its Board of Directors. In order to focus on his new role, Dr. Newman resigned his position from the Chemaphor Board.
